Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Yoshitomi discloses cytokine production inhibitors for treating and preventing allergic reactions

Aug. 25, 1999

FDA expands HUD designation for Ortec's Composite Cultured Skin

Aug. 25, 1999

Two new RAR antagonists emerge from retinoid research program at Bristol-Myers Squibb

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

L'Oreal compounds prevent skin aging in experimental models

Aug. 23, 1999

Zenyaku Kogyo will develop and market novel psoriasis treatment in Japan

Aug. 20, 1999

Gliatech's IDE for ADCON-L approved by FDA

Aug. 20, 1999

IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham

Aug. 16, 1999

Welsh academic team studies inhibitors of retinoic acid metabolism for dermatology applications

Aug. 12, 1999

Antiallergic quinoline compounds prepared and tested by Dainippon Ink & Chemicals

Aug. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...